The Advisory Committee on Immunization Practices (ACIP) recently approved recommendations for shingles (herpes zoster) vaccines and mumps-containing vaccines, in addition to approving the 2018 immunization schedules.
ACIP advises the Centers for Disease Control and Prevention (CDC). Once CDC approves ACIP’s recommendations, they will be published in the Morbidity and Mortality Weekly Report (MMWR), at which time the recommendations will become official CDC policy.
ACIP voted that herpes zoster subunit (HZ/su) vaccine is:
- recommended for the prevention of herpes zoster and related complications for immunocompetent adults aged 50 years and older,
- recommended for the prevention of herpes zoster and related complications for immunocompetent adults who previously received zoster vaccine live (ZVL),
- preferred over ZVL for the prevention of herpes zoster and related complications.
- ACIP voted that persons previously vaccinated with two doses of a mumps-containing vaccine* who are identified by public health as at increased risk for mumps because of an outbreak should receive a third dose of a mumps-containing vaccine to improve protection against mumps disease and related complications.
*As stated in Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP); wording includes MMR and MMRV
Once published in the MMWR, CDC will add shingles and mumps vaccination information and educational materials to CDC’s website.
2018 Immunization Schedules
ACIP approved the 2018 Recommended Immunization Schedules for Children and Adolescents Aged 18 Years or Younger and the Recommended Schedules for Adults aged 19 Years or Older. The adult schedule will reflect the new herpes zoster vaccine recommendation. The new mumps vaccination recommendation will be reflected in footnotes. The schedules will also incorporate all actions taken by ACIP this year. The 2018 schedules will be released early next year with information about changes.
‘Netconference’ Will Address Hepatitis A and New ACIP Recommendations
CDC will host a “Current Issues in Immunization Netconference” on Wednesday, November 8, at 12:00 – 1:00 p.m. EST. This Netconference, designed to provide health care providers with the most up-to-date information on immunization, will discuss these new recommendations. The netconference will also provide information about hepatitis A guidance and consideration in light of recent hepatitis A outbreaks and current constraints related to the hepatitis A vaccine supply. Registration is available online. Registration is limited; however, an archived version will be posted to CDC’s website shortly after November 8.
< Previous Article | Next Article >